(Q39874224)

15 September 2017

1 reference

title

Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs (English)

1 reference

15 September 2017

1 reference

Shand DG

1

1 reference

15 September 2017

1 January 1974

1 reference

15 September 2017

1 reference

15 September 2017

7

1 reference

15 September 2017

39-47

1 reference

15 September 2017

1

1 reference

Relation of propranolol plasma level to beta-blockade during oral therapy

15 September 2017

1 reference

12 December 2020

Relative potency of intravenous prinodolol and propranolol in man.

1 reference

12 December 2020

Metabolic studies on oxprenolol in animals and man by means of radio-tracer techniques and GLC-analysis

1 reference

12 December 2020

Multicenter trial of propranolol in angina pectoris

1 reference

12 December 2020

Plasma propranolol levels in adults With observations in four children

1 reference

12 December 2020

Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man

1 reference

12 December 2020

Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol

1 reference

12 December 2020

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

1 reference

12 December 2020

Influence of route of administration on drug availability

1 reference

12 December 2020

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

1 reference

12 December 2020

Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate

1 reference

12 December 2020

Pharmacodynamics of Propranolol in Renal Failure

1 reference

12 December 2020

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

1 reference

12 December 2020

Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels

1 reference

12 December 2020

Propranolol Dose Determinants Including Blood Level Studies

1 reference

12 December 2020

Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

1 reference

12 December 2020

Influence of First-Pass Effect on Availability of Drugs on Oral Administration

1 reference

12 December 2020

The disposition of propranolol. I. Elimination during oral absorption in man

1 reference

12 December 2020

The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat

1 reference

12 December 2020

Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man

1 reference

12 December 2020

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

1 reference

12 December 2020

Correlation of beta blockade with serum practolol levels after oral administration

1 reference

12 December 2020

A comparison of intravenous pindolol and propranolol in normal man.

1 reference

12 December 2020

Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites

1 reference

12 December 2020

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

1 reference

12 December 2020

Absorption of alprenolol in man from tablets with different rates of release

1 reference

12 December 2020

The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol

1 reference

12 December 2020

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

1 reference

12 December 2020

The pharmacokinetics of unchanged pindolol in patients with impaired renal function

1 reference

12 December 2020

Identifiers

PubMed ID

4151694

1 reference

PubMed ID

4151694